We have located links that may give you full text access.
Synthesis and bioactivity assessment of Coccinia grandis L. extract encapsulated alginate nanoparticles as an antidiabetic drug lead.
Journal of Microencapsulation 2023 November 16
Aim: To prepare, characterize, and evaluate antidiabetic activity of Coccinia grandis (L.) extracts encapsulated alginate nanoparticles. Methods: Alginate nanoparticles were prepared using ionic gelation method and characterized by encapsulation efficiency %w/w, loading capacity %w/w, particle size analysis, zeta potential, FTIR, and SEM. In vitro antidiabetic activity was also evaluated. Results: Encapsulation efficiency %w/w, loading capacity %w/w, mean diameter, zeta potential of C. grandis encapsulated alginate nanoparticles ranged from 10.51 ± 0.51 to 62.01 ± 1.28%w/w, 0.39 ± 0.04 to 3.12 ± 0.11%w/w, 191.9 ± 76.7 to 298.9 ± 89.6 nm, -21.3 ± 3.3 to -28.4 ± 3.4 mV respectively. SEM and FTIR confirmed that particles were in nano range with spherical shape and successful encapsulation of plant extracts into an alginate matrix The antidiabetic potential of aqueous extract of C. grandis (AqCG) encapsulated alginate nanoparticles (AqCG-ANP) exhibited inhibition in α-amylase, α-glucosidase and DPP-IV enzymes of 60.8%c/c, 19.1%c/c, and 30.3%c/c, respectively, compared to the AqCG. Conclusion: The AqCG-ANP exerted promising antidiabetic potential as an antidiabetic drug lead.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app